FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used for treating luetic optic neuropathy. That is ensured by subconjunctival administration of Cefazolin 0.3-0.5 mg. That is combined with intramuscular injection of Gliatilin 2.0-4.9 ml, 1-3% Glutoxim 2.0 ml and Milgamma 1.0-2.0 ml. Dexazon 0.5 ml is introduced parabulbarly. The preparations are introduced once a day for 10 days. Additionally, starting with the first therapeutic day, 10 sessions of percutaneous transcranial magnetic stimulation of the optic nerves are conducted daily.
EFFECT: method provides improving the visual functions and eliminating the complications of the central nervous system due to the integrated treatment developed with the severity of the pathological process in these patients.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING TOXIC OPTIC NEUROPATHY, INDUCED BY LONG INTAKE OF CODEINE-CONTAINING MEDICATIONS | 2010 |
|
RU2424796C1 |
| METHOD OF TREATING CHRONIC TOXIC ALCOHOL- AND TOBACCO-RELATED OPTIC NEUROPATHY | 2010 |
|
RU2440074C1 |
| METHOD OF TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2578953C1 |
| METHOD OF TREATING OPTIC NEUROPATHY AFTER CRANIOCEREBRAL INJURY IN REMOTE PERIOD | 2009 |
|
RU2398553C1 |
| METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 |
|
RU2622759C1 |
| METHOD FOR TREATING OPTIC NEURITIS AT OPTICOCHIASMIC ARACHNOIDITIS AT REMISSION STAGE | 2005 |
|
RU2284814C1 |
| METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
| METHOD FOR TREATING ACUTE VASCULAR OPTIC NEUROPATHY | 2005 |
|
RU2281071C1 |
| METHOD OF TREATING MONOCULAR OPTIC NEURITIS ACCOMPANYING MULTIPLE SCLEROSIS | 2013 |
|
RU2523146C1 |
| METHOD FOR THE TREATMENT OF ACUTE OPTIC NEUROPATHY IN DRUSEN OF THE OPTIC NERVE HEAD | 2022 |
|
RU2794569C1 |
